Quantcast
Home > Quotes > CRY

CryoLife, Inc. Common Stock (CRY) Quote & Summary Data

CRY 
$29.04
*  
0.50
1.75%
Get CRY Alerts
*Delayed - data as of Nov. 15, 2018  -  Find a broker to begin trading CRY now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    CRY After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
34.75
Today's High / Low
$ 29.08 / $ 28.30
Share Volume
100,185
90 Day Avg. Daily Volume
153,486
Previous Close
$ 28.54
52 Week High / Low
$ 36.05 / $ 16.80
Market Cap
1,073,536,374
P/E Ratio
NE
Forward P/E (1y)
86.48
Earnings Per Share (EPS)
$ -0.15
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0.42 %
Beta
0.98

Intraday Chart

Shares Traded

Share Volume:
100,185
90 Day Avg. Daily Volume:
153,486

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
86.48
Earnings Per Share (EPS):
$ -0.15

Trading Range

The current last sale of $29.04 is 72.86% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 29.08 $ 36.05
 Low: $ 28.30 $ 16.80

Company Description (as filed with the SEC)

CryoLife, Inc. ("CryoLife," the "Company," "we," or "us"), incorporated in 1984 in Florida, is a leader in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures focused on aortic repair. Our medical devices and processed tissues primarily include four product families: BioGlue® Surgical Adhesive ("BioGlue"); On-X mechanical heart valves and surgical products; JOTEC endovascular and surgical products; and cardiac and vascular human tissues including the CryoValve®SG pulmonary heart valve ("CryoValve SGPV") and the CryoPatch® SG pulmonary cardiac patch ("CryoPatch SG"), both of which are processed using our proprietary SynerGraft® technology. Additional products include CardioGenesis cardiac laser therapy, PerClot® and PhotoFixTM.  ... More ...  


Risk Grade

Where does CRY fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x